ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,527.86
0.34%
US Tech 100
19,604.60
0.64%
Dow Jones
39,287.13
-0.11%
Brent Oil
86.17
-0.32%
Bitcoin
60,177.49
-2.98%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ImmunoPrecise Antibodies Ltd (IPA)

  7. ImmunoPrecise Antibodies Ltd (IPA) News

IPA

ImmunoPrecise Antibodies (IPA)

ImmunoPrecise Antibodies Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IPA
DateTimeSourceHeadlineSymbolCompany
09/08/20229:03AMBusiness WireIPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022NASDAQ:IPAImmunoPrecise Antibodies Ltd
08/29/20225:38PMBusiness WireLes tests sur virus vivant à la Ludwig-Maximilians-Universität de Munich confirment l'efficacité du PolyTope contre les variants du SRAS-CoV-2, y compris le BA.5NASDAQ:IPAImmunoPrecise Antibodies Ltd
08/29/20228:09AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
08/29/20228:04AMBusiness WireLive Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope’s Efficacy Against SARS-CoV-2 Variants Including BA.5NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/29/20222:25PMBusiness WireImmunoPrecise publie ses résultats financiers et les temps forts de ses activités pour l'exercice 2022NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/29/20228:19AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/29/20228:04AMBusiness WireImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2022NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/26/202211:26AMBusiness WireIPA publiera ses résultats financiers et son actualité commerciale pour le quatrième trimestre et l'exercice fiscal 2022 le 29 juillet 2022NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/26/20228:13AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/26/20228:04AMBusiness WireIPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2022 on July 29, 2022NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/12/20229:35PMBusiness WireLes données histopathologiques de l'étude préclinique de toxicité à doses répétées et l'analyse ex vivo de la réactivité croisée des tissus humains confirment l'innocuité du PolyTope® TATX-03 d'IPA, un cocktail d'anticorps synergique contre leNASDAQ:IPAImmunoPrecise Antibodies Ltd
07/12/20228:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
07/12/20228:04AMBusiness WireHistopathology Data of Preclinical Repeated Dose Toxicity Study and ex vivo Human Tissue Cross-Reactivity (TCR) Analysis Support Safety of IPA’s PolyTope® TATX-03, a Synergistic Antibody Cocktail against SARS‑CoV‑2NASDAQ:IPAImmunoPrecise Antibodies Ltd
05/10/20222:03AMBusiness WireBioStrand, filiale d'IPA, reçoit une seconde subvention de recherche de VLAIONASDAQ:IPAImmunoPrecise Antibodies Ltd
05/09/20229:18AMInvestorsHub NewsWireIPA's Subsidiary BioStrand Secures Second VLAIO Research GrantNASDAQ:IPAImmunoPrecise Antibodies Ltd
05/09/20228:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
05/09/20228:03AMBusiness WireIPA’s Subsidiary BioStrand Secures Second VLAIO Research GrantNASDAQ:IPAImmunoPrecise Antibodies Ltd
04/25/20221:14PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
04/20/20228:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
04/14/202210:19AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
04/14/20228:09AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
04/14/20228:06AMInvestorsHub NewsWireIPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and OfferingsNASDAQ:IPAImmunoPrecise Antibodies Ltd
04/12/20221:42PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
03/29/202211:48AMInvestorsHub NewsWireIPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial IntelligenceNASDAQ:IPAImmunoPrecise Antibodies Ltd
03/29/20228:51AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
03/16/20228:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
03/14/20229:35AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
03/14/20229:04AMInvestorsHub NewsWireIPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of DefenseNASDAQ:IPAImmunoPrecise Antibodies Ltd
03/09/20228:07AMInvestorsHub NewsWireIPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03NASDAQ:IPAImmunoPrecise Antibodies Ltd
03/08/20228:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IPAImmunoPrecise Antibodies Ltd
 Showing the most relevant articles for your search:NASDAQ:IPA

Your Recent History

NASDAQ
TSLA
Tesla
USOTC
NNAX
New Momentum (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
AXXA
Exxe (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
MGON
Megola (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
CNNA
Cann American (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved